BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21274378)

  • 1. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
    Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
    World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
    de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
    Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
    Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
    Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
    Wu D; Wu Y; Zhang X; Cong P; Lv X
    Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between polymorphisms of epidermal growth factor gene and silicosis].
    Jiang DP; Wang CY; Fan XY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Nov; 31(11):820-4. PubMed ID: 24370290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between EGF +61 A>G polymorphism and gastric cancer risk: A meta-analysis.
    Wu SJ; Jiang SY; Wu J; Xiong GL
    J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):327-332. PubMed ID: 26072068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
    BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
    Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
    Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
    Tao Y; Liang G
    Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.
    Li TF; Ren KW; Liu PF
    DNA Cell Biol; 2012 Apr; 31(4):568-74. PubMed ID: 22070650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
    Cacina C; Arikan S; Düzköylü Y; Doğan MB; Okay E; Turan S; Yaylim I; Isbir T
    Anticancer Res; 2015 May; 35(5):2709-13. PubMed ID: 25964549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
    Hamai Y; Matsumura S; Matsusaki K; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Toge T; Yasui W
    Pathobiology; 2005; 72(3):133-8. PubMed ID: 15860930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-α 238 G/A polymorphism and gastric cancer risk: a meta-analysis.
    Yu JY; Li L; Ma H; Liu K; Cheng X; Li YL; Song XL
    Tumour Biol; 2013 Dec; 34(6):3859-63. PubMed ID: 23900678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
    Peng Q; Li S; Qin X; Lao X; Chen Z; Zhang X; Chen J
    Cancer Cell Int; 2014; 14():134. PubMed ID: 25729328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
    Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
    Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
    Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
    Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
    da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
    Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS
    J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.